NCT02565823 The Effects of Exercise of Secreted Factors From Muscle and Adipose Tissue Status COMPLETED Phase NA
NCT02564900 Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors Status COMPLETED Phase PHASE1
NCT02560688 Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02533960 Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime Status COMPLETED Phase N/A
NCT02530918 Study of DS-7080a for the Treatment of Macular Degeneration Status COMPLETED Phase PHASE1
NCT02514304 Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding Status COMPLETED Phase N/A
NCT02496884 Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease Status COMPLETED Phase PHASE3
NCT02478177 Addressing Real-world Anticoagulant Management Issues in Stroke Status COMPLETED Phase N/A
NCT02473627 A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS Status COMPLETED Phase PHASE1
NCT02452424 A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02448901 Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography Status UNKNOWN Phase N/A
NCT02448628 A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment Status COMPLETED Phase PHASE2
NCT02371369 Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) Status COMPLETED Phase PHASE3
NCT02356432 Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW) Status UNKNOWN Phase N/A
NCT02350712 Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT02345057 A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria Status COMPLETED Phase PHASE2
NCT02345044 A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects Status COMPLETED Phase PHASE2
NCT02339493 Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter Status COMPLETED Phase NA
NCT02319369 Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) Status TERMINATED Phase PHASE1